White House trade adviser Peter Navarro said on Thursday that the Trump administration is likely to levy tariffs on pharmaceutical imports under a “Section 232” trade investigation because it’s “very clear that we have a national security crisis” due to U.S. reliance on foreign producers in the sector.<\/p>\n
In an televised interview with CNBC, Navarro did not provide any details on the timing of the Section 232 probe.<\/p>\n
He said that President Donald Trump’s executive order to shore up supply chains will provide price floors for domestic producers of drug ingredients through long-term strategic contracts that will ensure sufficient demand. At the same time, tariffs will deter dumping of pharma precursors from India and China, he added.<\/p>\n","protected":false},"excerpt":{"rendered":"
White House trade adviser Peter Navarro said on Thursday that the Trump administration is likely to levy tariffs on pharmaceutical imports under a “Section 232” trade investigation because it’s “very clear that we have a national security crisis” due to U.S. reliance on foreign producers in the sector. In an televised interview with CNBC, Navarro […]<\/p>\n","protected":false},"author":2,"featured_media":1427,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[336],"class_list":{"0":"post-1426","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sitefansalaran-international-news","8":"tag-white-houses-navarro-says-pharma-tariffs-likely-under-section-232-probe"},"yoast_head":"\n